Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10295093" target="_blank" >RIV/00216208:11110/15:10295093 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/15:10295093
Result on the web
<a href="http://dx.doi.org/10.1093/ndt/gfu328" target="_blank" >http://dx.doi.org/10.1093/ndt/gfu328</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/ndt/gfu328" target="_blank" >10.1093/ndt/gfu328</a>
Alternative languages
Result language
angličtina
Original language name
Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis
Original language description
Despite major advances in the management of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) achieved in the last decades, a large proportion of AAV patients still develop end-stage renal disease. The survival of AAV patients dependent on dialysis is significantly worse compared with dialysis-independent AAV patients, but is comparable to other non-diabetic patients requiring dialysis. Renal transplantation (RTx) is the method of choice among renal replacement therapies and there has been increasing evidence that it is a suitable method with favorable patient- and graft-survival also in AAV patients. It is recommended to perform RTx after a parts per thousand yen12 months of remission, and ANCA positivity at the time of RTx isgenerally not considered a contraindication. Even though the risk of relapse after RTx is relatively low with current post-transplant immunosuppressive regimens, disease recurrence may occur. Besides cyclophosphamide, rituximab might beco
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Nephrology Dialysis Transplantation
ISSN
0931-0509
e-ISSN
—
Volume of the periodical
30
Issue of the periodical within the volume
Supplement 1
Country of publishing house
GB - UNITED KINGDOM
Number of pages
5
Pages from-to
"i159"-"i163"
UT code for WoS article
000353500300023
EID of the result in the Scopus database
2-s2.0-84926640643